GL1X · GenesisL1 explorer

Research workbench

Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18

Analyse Structure of the kinase domain of human RIPK2 in complex with the inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FU5
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-interacting SERINE/THREONINE-protein kinase 2
EC
2.7.11.1, 2.7.10.2
UniProt
O43353
Ligands
E7N
Pockets
8 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein28241% helix, 17% strandO43353
BReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein28640% helix, 16% strandO43353

Ligands and binding sites

  • E7N · ~{N}-[5-[2-azanyl-5-(4-piperazin-1-ylphenyl)pyridin-3-yl]-2-methoxy-phenyl]propane-1-sulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110950.830.8480empty
22760.690.8431E7N
33020.680.8329E7N
41320.480.7829empty
51010.380.7516empty

Interfaces

1 interface between chains.

  • A–B · 2042 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 6FU5 · Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.